Plus Therapeutics Inc Share Price

NASDAQ: PSTV

Small Cap

$0.42

-0.01

(-2.26%)

as on September 18, 2025 at 1:29 am IST

$₹

Plus Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$0.41
Day's Price Range
$0.43
$0.42
2.38%
Downside
2.38%
Upside
52 Week's Low
52 Week's High
$0.16
52-Week Price Range
$2.31
$0.42
61.10%
Downside
449.98%
Upside

Plus Therapeutics Inc share price movements today

Previous Close: $0.43
Open: $0.42
Volume: 4.3M
Day's Low - High: $0.41 - $0.43
52 Week Low - High: $0.16 - $2.31

Plus Therapeutics Inc Historical Returns

1 Month Return: -20.71 %
3 Month Return: + 109.93 %
1 Year Return: -73.76 %
3 Year Return: -95.28 %
5 Year Return: -99.04 %

Plus Therapeutics Inc Stock Fundamentals & Key Indicators

Check Plus Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$41.4M

EPS (TTM)

-0.33

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.63

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-12.2M

Revenue (TTM)

5.3M

Profit Margin

0.00%

Return On Equity TTM

90508500.00%

Plus Therapeutics Inc Stock Valuation

Track how Plus Therapeutics Inc P/E has moved over time to understand its valuation trends.

Plus Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 18, 2025

Industry (0.00x)

September 18, 2025

Today (-0.63x)

September 18, 2025

Highest (-0.56x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.63x

Plus Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Plus Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Plus Therapeutics Inc	BUY	$41.4M	-99.04%	-0.63	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	248.74%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Plus Therapeutics Inc Stock including INR - Dollar returns

The Plus Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Plus Therapeutics Inc investment value today

Current value as on today

₹30,524

Returns

₹69,476

(-69.48%)

Returns from Plus Therapeutics Inc Stock

₹74,074 (-74.07%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Plus Therapeutics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Plus Therapeutics Inc. Average target price of $7.88

Plus Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Plus Therapeutics Inc.

What analysts predicted

94.67%UPSIDE

Target Price

$7.88

Current Price

$0.42

Analyzed by

10 Analysts

Target

$7.88

Plus Therapeutics Inc target price $7.88, a slight upside of 94.67% compared to current price of $0.42. According to 10 analysts rating.

Plus Therapeutics Inc Stock's Interest Amongst Investors

Investment in Plus Therapeutics Inc Shares on INDmoney has dropped by -56.53% over the past 30 days, indicating reduced transactional activity.

Time period: August 19, 2025 to September 18, 2025

Change:-56.53% versus previous 30 day period

Search interest for Plus Therapeutics Inc Stock has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-59% versus previous 30 day period

Plus Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	1	1	1	1	1	1	1	1	1
Gross Profit	0	1	1	1	1	-1	1	1	0	1
Operating Income	-4	-1	-3	-3	-3	-3	-3	-3	-3	-1
EBITDA	-4	-1	-2	-3	-3	0	-2	-3	-13	5
Interest Expense	0	0	0	0	0	3	0	0	3	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-1	-3	-3	-3	-2	-2	-3	-17	5
Income Tax Expense	0	0	0	0	0	-	-	-	-	-
Net Income	-4	-1	-3	-3	-3	-2	-2	-3	-17	5
Net Profit Margin	-949.60%	-79.94%	-259.60%	-290.18%	-194.45%	-229.87%	-197.39%	-276.42%	-1643.15%	370.58%

Plus Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	11	11	6	2	6	0	-	0	4	5
Gross Profit	8	8	5	1	1	-2	0	0	-4	4
Operating Income	-15	-19	-20	-8	-3	-9	-12	-19	-13	-14
EBITDA	-21	-18	-18	-6	0	-6	-12	-18	-12	-8
Interest Expense	3	2	2	1	1	1	0	0	0	3
Depreciation	-	-	2	2	0	0	0	0	0	0
Income Before Tax	-18	-22	-22	-8	-3	-8	-13	-20	-13	-12
Income Tax Expense	3	2	2	1	9	1	0	0	-	-
Net Income	-18	-22	-22	-12	-10	-8	-13	-20	-13	-12
Net Profit Margin	-160.77%	-193.73%	-353.86%	-423.53%	-155.57%	-2719.80%	0.00%	-9051.34%	-271.04%	-222.84%

Plus Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-1	-3	-3	-3	-2	-2	-3	-17	5
Operating Cash Flow	-2	-2	-1	-4	-1	-3	-1	-6	-5
Investing Cash Flow	0	0	0	0	-3	0	0	3	-4
Financing Cash Flow	0	2	0	0	6	-	-	12	2
Change in Cash	-1	0	-2	-5	2	-3	-1	9	-7

Plus Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-22	-22	-12	-10	-8	-13	-20	-13	-12
Operating Cash Flow	-19	-18	-11	-5	-8	-10	-12	-12	-10
Investing Cash Flow	0	-1	0	5	0	0	0	0	-4
Financing Cash Flow	17	16	7	12	0	20	13	3	6
Change in Cash	-1	-2	-4	12	-9	10	0	-9	-8

Global Institutional Holdings in Plus Therapeutics Inc

Funds	Holdings
HRT FINANCIAL LLC	0.2%
Susquehanna International Group, LLP	0.16%
Geode Capital Management, LLC	0.11%
Virtu Financial LLC	0.08%
UBS Group AG	0.07%

See all

Insights on Plus Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 1.05M → 1.39M (in $), with an average increase of 23.8% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -17.40M → 5.15M (in $), with an average increase of 437.8% per quarter
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 142.7%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 206.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, PSTV stock has moved down by -11.3%

About Plus Therapeutics Inc

plus therapeutics, inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and manufacture of treatments for cancer and other diseases. its lead product candidate is doceplus, a protein-stabilized pegylated liposomal formulation of docetaxel for the treatment of small cell lung cancer. the company is also involved in developing doxoplus, a generic pegylated liposomal encapsulated doxorubicin to treat breast and ovarian cancer, multiple myeloma, and kaposi's sarcoma. it has a license agreement with nanotx, corp. to develop and commercialize nanotx's glioblastoma treatment. the company was formerly known as cytori therapeutics, inc. and changed its name to plus therapeutics, inc. in july 2019. plus therapeutics, inc. was founded in 1996 and is headquartered in austin, texas.

Organisation	Plus Therapeutics Inc
Headquarters	2710 Reed Road, Houston, TX, United States, 77051
Industry	Health Technology
CEO	Dr. Marc H. Hedrick M.B.A., M.D.
E-voting on shares	Click here to vote

Key Management of Plus Therapeutics Inc

Name	Title
Dr. Michael Stanley Rosol Ph.D.	Chief Development Officer
Ms. Desiree Smith	Corporate Controller
Mr. Russell W. Bradley	President & GM of CNSide Diagnostics
Dr. Marc H. Hedrick M.B.A., M.D.	President, CEO & Director
Mr. Andrew J. Sims CPA	VP of Finance & CFO

FAQs

What is Plus Therapeutics Inc share price today?

Plus Therapeutics Inc share price today is $0.42 as on September 18, 2025 at 1:29 am IST at the close of the market. Plus Therapeutics Inc share today touched a day high of $0.43 and a low of $0.41.

What is the 52 week high and 52 week low for Plus Therapeutics Inc share?

Plus Therapeutics Inc share touched a 52 week high of $2.31 on March 7, 2025 and a 52 week low of $0.16 on June 18, 2025. Plus Therapeutics Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $0.42,which is 81.82% down from its 52 week high and 157.04% up from its 52 week low.

What is Plus Therapeutics Inc's market capitalisation today?

Plus Therapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Plus Therapeutics Inc Stock (PSTV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Plus Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Plus Therapeutics Inc Shares that will get you 3.5714 shares as per Plus Therapeutics Inc share price of $0.42 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Plus Therapeutics Inc Stock (PSTV) from India?

Indian investors can start investing in Plus Therapeutics Inc (PSTV) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 2:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Plus Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 2:44 pm IST). Based on Plus Therapeutics Inc share’s latest price of $0.42 as on September 18, 2025 at 1:29 am IST, you will get 23.8095 shares of Plus Therapeutics Inc. Learn more about fractional shares .

What are the returns that Plus Therapeutics Inc has given to Indian investors in the last 5 years?

Plus Therapeutics Inc stock has given -99.04% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?